CIK: 0000315157 · Show all filings
Period: Q4 2021 (← Previous) (Next →)
Filing Date: Feb 2, 2022
Total Value ($000): $2,258,101 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| JNJ | JOHNSON & JOHNSON (JNJ) | 12,518,000 | $2,141,454 | 94.8% | $59.66 | +143.2% | Common | 478160104 |
| OBDC | OWL ROCK CAPITAL CORP | 4,123,202 | $58,385 | 2.6% | $7.01 | +27.6% | Common | 69121K104 |
| RPRX | ROYALTY PHARMA PLC | 970,151 | $38,661 | 1.7% | $49.50 | -21.5% | Common | G7709Q104 |
| KCCA | KRANESHARES California Global | 495,826 | $14,002 | 0.6% | $28.24 | — | ETF | 500767553 |
| KRBN | KRANESHARES Global Carbon | 110,000 | $5,599 | 0.2% | $41.08 | — | ETF | 500767678 |